Nektar Therapeutics (NKTR) Q4 Earnings Beat Estimates
Nektar (NKTR) delivered earnings and revenue surprises of 215.38% and 25.23%, respectively, for the quarter ended December 2024. Do the…
0,682€
8,43%
Echtzeit-Aktienkurs Nektar Therapeutics Corp.
Bid:
Ask:
Nachrichten zur Nektar Therapeutics Corp. Aktie
Nektar Therapeutics chief R&D officer sells $48,048 in stock By Investing.com
Nektar Therapeutics chief R&D officer sells $48,048 in stock…
Multiple Catalysts Ahead For Nektar Therapeutics
…
Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Transcript
…
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates
Nektar (NKTR) delivered earnings and revenue surprises of -19.05% and 36.26%, respectively, for the quarter ended June 2024. Do the…
Nektar Therapeutics Likely To Drift And Wobble Ahead Of Key Phase II Data In 2025
…
Nektar Therapeutics executive sells over $12k in shares By Investing.com
Nektar Therapeutics executive sells over $12k in shares…
Nektar Therapeutics, Inc. (NKTR) Q1 2024 Earnings Call Transcript
…
Earnings call: Nektar Therapeutics unveils drug development progress By Investing.com
Earnings call: Nektar Therapeutics unveils drug development progress…
Nektar Therapeutics (NKTR) Q4 2023 Earnings Call Transcript
…
Nektar Therapeutics secures $30 million in private financing By Investing.com
Nektar Therapeutics secures $30 million in private financing…
Nektar Therapeutics Q4 2023 Earnings Preview
…